List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 49 studies with search of: "HIV Therapeutic Vaccine" [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
Condition: HIV Infections
Intervention: Biological: recombinant HIV-1 Tat protein
2 Completed Safety and Tolerability of and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving Anti-HIV Treatment
Condition: HIV Infections
Interventions: Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccination
3 Active, not recruiting Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
Condition: HIV Infections
Interventions: Biological: MRK Ad5 HIV-1 gag vaccine;   Other: Vaccine placebo
4 Terminated Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: Aluminum hydroxide;   Biological: QS-21;   Biological: MN rsgp120/HIV-1
5 Active, not recruiting A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: gp160 MN/LAI-2
6 Completed Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Condition: HIV Infections
Intervention: Biological: ALVAC(2)120(B,MN)GNP (vCP1452)
7 Active, not recruiting The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A (TB vaccine);   Biological: MVA 85A
8 Completed A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
Condition: HIV Infections
Intervention:
9 Completed A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Biological: gp160 Vaccine (Immuno-AG);   Drug: Stavudine;   Drug: Didanosine
10 Active, not recruiting Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Keyhole-Limpet Hemocyanin
11 Recruiting Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
12 Recruiting Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infections
Intervention: Biological: HIV gp120/NefTat/AS02A Vaccine
13 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
Condition: HIV Infections
Interventions: Biological: gp160 Vaccine (Immuno-AG);   Biological: Hepatitis B Vaccine (Recombinant)
14 Completed Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
Condition: HIV Infections
Intervention: Biological: Dendritic Cells Pulsed with HIV antigens
15 Completed Efficacy Study of T Cell Vaccination in HIV Infection
Condition: HIV Infections
Intervention: Biological: T cell vaccination
16 Completed Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections;   Pregnancy
Intervention: Biological: rgp120/HIV-1MN
17 Recruiting Dendritic Cell Vaccine in HIV-1 Infection
Condition: HIV Infections
Intervention: Biological: Dendritic cell vaccine
18 Completed A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
Condition: HIV Infections
Interventions: Biological: Tetanus Toxoid Vaccine;   Biological: Hepatitis A Vaccine (Inactivated);   Biological: HIV-1 Immunogen;   Biological: Hepatitis B Vaccine (Recombinant)
19 Terminated Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections;   Pregnancy;   HIV Seronegativity
Interventions: Biological: MF59;   Biological: rgp120/HIV-1 SF-2
20 Completed Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
Condition: HIV Infections
Interventions: Biological: rMVA-HIV (env/gag [TBC-M358] + tat/rev/nef-RT [TBC-M335)]);   Biological: rFPV-HIV (env/gag [TBC-F357] + tat/rev/nef-RT [TBC-F349])

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services